This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon

Adria Cimino, The Motley Fool
·4 min read
This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon

Vertex Pharmaceuticals (NASDAQ: VRTX) is the leader in cystic fibrosis (CF) treatment -- and it expects to hold that title until at least the late 2030s. The biotech company may be about to prove that, yes, it can. Vertex CEO Reshma Kewalramani made a statement about one of the company's most innovative, exciting programs during the recent earnings call.